Volume 1
HCV cure for everyone or which challenges remain?
Jürgen Rockstroh
HIV persistence in the setting of antiretroviral therapy
Deanna A Kulpa & Nicolas Chomont
CNS reservoirs for HIV: implications for eradication
Joanna Hellmuth, Victor Valcour, Serena Spudich
Clinical outcomes and antiretroviral therapy in ‘elite’ controllers
Trevor A Crowell & Hiroyu Hatano
New prospects for a preventive HIV-1 vaccine
Jeffrey Brown, Jean-Louis Excler, Jerome H Kim
Low incidence of HIV infection in anonymous HIV counselling
Nittaya Phanuphak, Robert Paris, Donn Colby et al.
Cervical and anal HPV infection
Reshmie A Ramautarsing & Nittaya Phanuphak et al.
Analysis of minimum target prices for production of entecavir
Andrew Hill, Dzintars Gotham, Graham Cooke et al.
Innovative strategies using communications technologies to engage
Tarandeep Anand & Chattiya Nitpolprasert, et al.
Markers of HIV reservoir size and immune activation after treatment in acute HIV
Jintanat Ananworanich, Nicolas Chomont, JLK Fletcher et al
CROI 2015: report
Jintanat Ananworanich, Linos Vanderkerckhove, Ya-Chi Ho, Claudia Alteri et al.
Highlights from HIV Research Prevention (R4P)
Julie Ake
We all need to know about HIV cure research
Olubanke Davies & Julie Fox